NCT00448929View on ClinicalTrials.gov

Ologen (OculusGen)-Glaucoma Case Control Trial in India

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Glaucoma
Interventions
DEVICE

OculusGen Biodegradable Collagen Matrix Implant

Trabeculectomy with OculusGen Biodegradable Collagen Matrix Implant

Trial Locations (1)

500 034

L. V. Prasad Eye Institute, Hyderabad

All Listed Sponsors
lead

Pro Top & Mediking Company Limited

INDUSTRY

NCT00448929 - Ologen (OculusGen)-Glaucoma Case Control Trial in India | Biotech Hunter | Biotech Hunter